Methylsulfonylmethane / COX2 Cancer Research Results

MSM, Methylsulfonylmethane: Click to Expand ⟱
Features:
MSM (Methylsulfonylmethane) is a naturally occurring organosulfur compound often used as a dietary supplement for its anti-inflammatory and antioxidant effects. While most well-known for joint health.
-MSM is actually a metabolite of DMSO (dimethyl sulfoxide) 
-Generally Recognized as Safe     Possible Interactions: aspirin, warfarin, NSAIDS

-Supplement dosage: 500mg 2-3times/day


-Anti-inflammatory: ↓NF-κB, ↓COX-2 and iNOS
-↓STAT3
-↓Cyclin D1 and CDK4, halting cell cycle progression.
-↓MMP-2, MMP-9, VEGF limiting invasion.

Methylsulfonylmethane (MSM) — Cancer-Oriented Time-Scale Flagged Pathway Table
Rank Pathway / Axis Cancer / Tumor Context Normal Tissue Context TSF Primary Effect Notes / Interpretation
1 NF-κB inflammatory transcription NF-κB ↓; COX-2/cytokines ↓ (reported) Inflammation tone ↓ R, G Anti-inflammatory signaling One of the most consistent findings in MSM studies is suppression of NF-κB-linked inflammatory signaling.
2 STAT3 signaling STAT3 phosphorylation ↓ (reported) ↔ R, G Pro-survival pathway suppression STAT3 inhibition has been reported in some breast and other tumor models; relevance depends on tumor type.
3 PI3K / AKT pathway AKT signaling ↓ (reported; model-dependent) ↔ R, G Growth modulation Observed in certain cell lines; should be presented as context-dependent rather than universal.
4 ROS / redox modulation ROS ↓ (often); oxidative stress tone ↓ Oxidative injury ↓ P, R, G Redox buffering MSM is generally described as anti-oxidative/anti-inflammatory rather than pro-oxidant; not a ROS-amplifying therapy.
5 Apoptosis induction Caspases ↑; Bax ↑; Bcl-2 ↓ (reported) ↔ G Cell death signaling Apoptotic effects reported in vitro; usually downstream of inflammatory and survival pathway suppression.
6 Cell-cycle regulation Cell-cycle arrest ↑ (reported) ↔ G Cytostasis Observed in some cancer cell systems; mechanism linked to signaling changes.
7 Migration / invasion (MMPs) MMP expression ↓; migration ↓ (reported) ↔ G Anti-invasive phenotype Reduction in metastasis markers reported in certain preclinical models.
8 ER stress modulation Stress signaling modulation (context-dependent) Proteostasis support R, G Stress pathway modulation Less consistent than NF-κB effects; should be kept qualified.
9 Chemo-/radiation interaction (theoretical) May reduce inflammatory toxicity; may blunt ROS-based therapies Normal tissue protection possible G Adjunct positioning Because MSM is anti-oxidative/anti-inflammatory, positioning with strong pro-oxidant therapies should be considered carefully.
10 Translation constraint Human anti-cancer efficacy not established Generally well tolerated in common supplement ranges — Evidence limitation Evidence base is largely preclinical; clinical oncology data are limited.

Time-Scale Flag (TSF): P / R / G

  • P: 0–30 min (early redox/inflammatory signaling shifts)
  • R: 30 min–3 hr (NF-κB / STAT3 pathway modulation)
  • G: >3 hr (cell-cycle, apoptosis, invasion phenotype changes)


For Alzheimer's (AD):
Methylsulfonylmethane (MSM) in neurobiology is primarily framed as an anti-inflammatory and redox-buffering molecule, not a direct amyloid-clearing or tau-targeting drug. Evidence is largely preclinical (cell + animal models). Position it as a neuroinflammation and oxidative stress modulator.
-Anti-inflammatory: ↓TNF-α, IL-1β, IL-6 
-↓ROS, ↑GSH, ↓NO
-may reduce Aβ plaque burden and tau hyperphosphorylation indirectly
-improves memory in rodents

Methylsulfonylmethane (MSM) — Alzheimer’s Disease (AD) Time-Scale Flagged Pathway Table
Rank Pathway / Axis AD / Brain Context TSF Primary Effect Notes / Interpretation
1 Neuroinflammation (NF-κB / cytokine signaling) Microglial activation ↓; IL-1β/TNF-α ↓ (reported) R, G Anti-inflammatory modulation MSM’s most consistent neuro-relevant signal is suppression of NF-κB-driven inflammatory tone, which is implicated in AD progression.
2 Oxidative stress / redox buffering Lipid peroxidation ↓; ROS tone ↓ (reported) R, G Neuroprotection (stress buffering) MSM is generally described as antioxidant/anti-inflammatory rather than pro-oxidant; may help mitigate oxidative injury.
3 Mitochondrial function support Mitochondrial stress ↓ (context-dependent) R, G Bioenergetic stabilization Indirect support through reduced oxidative and inflammatory burden; not a primary mitochondrial activator.
4 ER stress / proteostasis modulation UPR signaling ↓ (reported in stress models) R, G Proteostasis buffering ER stress is relevant in AD pathology; MSM may attenuate stress signaling in some models.
5 Calcium homeostasis modulation Excitotoxic stress ↓ (indirect) P, R Signal stabilization Primarily indirect via inflammatory and oxidative stress reduction.
6 Aβ pathology (direct evidence) Limited direct evidence of amyloid reduction G Indirect modulation If effects occur, they are likely secondary to reduced oxidative stress and inflammation rather than direct amyloid targeting.
7 Tau phosphorylation Limited direct mechanistic evidence G Indirect modulation No strong mechanistic evidence that MSM directly modulates tau kinases; effects likely indirect.
8 Blood–brain barrier (BBB) considerations CNS exposure plausible but not strongly quantified R PK consideration Systemic exposure is good; CNS-specific pharmacokinetics are less clearly defined.
9 Cognitive outcome evidence Limited direct human AD trial data — Translation constraint Evidence base is largely mechanistic/preclinical; clinical AD efficacy not established.

Time-Scale Flag (TSF): P / R / G

  • P: 0–30 min (early redox/inflammatory signaling shifts)
  • R: 30 min–3 hr (microglial signaling + oxidative stress modulation)
  • G: >3 hr (phenotype-level neuroprotection effects)
COX2, cycloocygenase-2 (Cox-2) mRNA and Cox-2 protein: Click to Expand ⟱
Source: HalifaxProj(inhibit)
Type:
Cyclooxygenase-2 (COX-2) is an enzyme that plays a critical role in the conversion of arachidonic acid to prostaglandins, which are lipid compounds involved in various physiological processes, including inflammation, pain, and fever. COX-2 is an inducible enzyme, meaning its expression is typically low in normal tissues but can be upregulated in response to inflammatory stimuli, growth factors, and certain oncogenic signals.
-Cyclooxygenase-2 (COX-2), the rate-limiting enzyme in prostaglandin biosynthesis, plays a key role in inflammation and circulatory homeostasis.
-COX-2 is an inducible enzyme that is upregulated in response to pro-inflammatory signals, including cytokines (e.g., IL-1β, TNF-α) and growth factors.

COX-2 is often overexpressed in various tumors, including colorectal, breast, lung, and prostate cancers.
The prostaglandins produced by COX-2, particularly prostaglandin E2 (PGE2), have several effects that can facilitate cancer progression:
Cell Proliferation: PGE2 can promote the proliferation of cancer cells by activating signaling pathways such as the PI3K/Akt and MAPK pathways.
Nonselective NSAIDs, such as aspirin and ibuprofen, inhibit both COX-1 and COX-2. Epidemiological studies have suggested that regular use of NSAIDs may reduce the risk of certain cancers, particularly colorectal cancer.
Drugs specifically targeting COX-2, such as celecoxib, have been developed.

COX-2 and xanthine oxidase are ROS-producing pro-oxidant enzymes that contribute to inflammation. Elevated COX‑2 levels, often found in inflammatory conditions or certain types of cancers, can contribute to increased production of ROS.
Scientific Papers found: Click to Expand⟱
3847- MSM,    Methylsulfonylmethane: Applications and Safety of a Novel Dietary Supplement
- Review, Arthritis, NA
*Inflam↓, *Pain↓, *ROS↓, *antiOx↑, *Dose↝, *Half-Life↝, *NF-kB↓, *IL1↓, *IL6↓, *TNF-α↓, *iNOS↓, *COX2↓, *NLRP3↓, *NRF2↑, *STAT↓, *Cartilage↑, *eff↑, *eff↑, *GSH↑, *uricA↓, tumCV↓, TumCCA↑, necrosis↑, Apoptosis↑, VEGF↓, HSP90↓, IGF-1?,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Cell Death ⓘ

Apoptosis↑, 1,   necrosis↑, 1,  

Transcription & Epigenetics ⓘ

tumCV↓, 1,  

Protein Folding & ER Stress ⓘ

HSP90↓, 1,  

Cell Cycle & Senescence ⓘ

TumCCA↑, 1,  

Proliferation, Differentiation & Cell State ⓘ

IGF-1?, 1,  

Angiogenesis & Vasculature ⓘ

VEGF↓, 1,  
Total Targets: 7

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress ⓘ

antiOx↑, 1,   GSH↑, 1,   NRF2↑, 1,   ROS↓, 1,   uricA↓, 1,  

Cell Death ⓘ

iNOS↓, 1,  

Proliferation, Differentiation & Cell State ⓘ

STAT↓, 1,  

Migration ⓘ

Cartilage↑, 1,  

Immune & Inflammatory Signaling ⓘ

COX2↓, 1,   IL1↓, 1,   IL6↓, 1,   Inflam↓, 1,   NF-kB↓, 1,   TNF-α↓, 1,  

Protein Aggregation ⓘ

NLRP3↓, 1,  

Drug Metabolism & Resistance ⓘ

Dose↝, 1,   eff↑, 2,   Half-Life↝, 1,  

Clinical Biomarkers ⓘ

IL6↓, 1,  

Functional Outcomes ⓘ

Pain↓, 1,  
Total Targets: 20

Scientific Paper Hit Count for: COX2, cycloocygenase-2 (Cox-2) mRNA and Cox-2 protein
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:124  Target#:66  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page